mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.041 |
0.4 |